Gujarat Themis Biosyn Ltd Falls 9.63%: Technical Weakness and Financial Pressures Shape the Week
2026-11-21 15:00:04Key Events This Week 16 Nov: Intraday low amid price pressure, stock falls 7.59% 17 Nov: Downgrade to Sell rating due to weak financials and bearish technicals 18 Nov: Mixed technical signals with sideways momentum 19 Nov: Mildly bearish technical momentum despite daily price gain 20 Nov: Continued decline closes week at Rs.351.75 (-1.80%) Week OpenRs.389.25...
Read More
Gujarat Themis Biosyn Ltd Faces Technical Momentum Shift Amid Mixed Indicators
2026-11-19 08:04:37Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 16 Nov 2026. Despite a 3.67% rise in the stock price on 19 Nov 2026, key technical indicators signal a transition from sideways to mildly bearish trends, raising concerns about near-term price sustainability.
Read More
Gujarat Themis Biosyn Ltd Faces Technical Setback Amid Mixed Momentum Signals
2026-11-18 08:04:13Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bearish stance to a sideways trend. The stock’s recent performance, combined with mixed technical signals, suggests a complex outlook for investors navigating this volatile phase.
Read More
Gujarat Themis Biosyn Ltd Faces Technical Downshift Amid Price Momentum Weakness
2026-11-17 08:03:10Gujarat Themis Biosyn Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a mildly bearish trend. The stock’s recent 7.59% decline and downgrade to a Sell rating reflect growing concerns among investors, despite its impressive long-term returns compared to the Sensex.
Read More
Gujarat Themis Biosyn Ltd Hits Intraday Low Amid Price Pressure
2026-11-16 09:33:37Gujarat Themis Biosyn Ltd witnessed a notable decline today, hitting an intraday low of Rs 361.25, reflecting a sharp price pressure of 7.19% as the stock underperformed its sector and broader market indices.
Read More
Gujarat Themis Biosyn Ltd is Rated Hold
2026-11-14 10:10:28Gujarat Themis Biosyn Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreGujarat Themis Biosyn Gains 4.57%: Technical Shift and Rating Upgrade Drive Momentum
2026-11-07 15:00:08Key Events This Week 2 Nov: Stock opens at Rs.362.50, Sensex at 34,248.59 3 Nov: Mojo Grade upgraded to Hold; stock rises 2.18% to Rs.377.25 4 Nov: Continued price gains with Rs.387.70 close (+2.77%) 6 Nov: Stock dips 2.23% to Rs.379.05 despite Sensex rise Week OpenRs.362.50 Week CloseRs.379.05...
Read More
Gujarat Themis Biosyn Ltd is Rated Sell
2026-10-31 10:10:24Gujarat Themis Biosyn Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 31 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Gujarat Themis Biosyn Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-10-30 08:02:09Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum and technical indicators, prompting a downgrade in its Mojo Grade from Hold to Sell as of 19 Oct 2026. Despite a strong weekly price gain, the stock’s broader technical landscape reveals a complex picture of mixed signals and sideways trend potential.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
17-Nov-2026 | Source : BSERecording of Analysts Meet held on 16.11.2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSENewspaper Publication of Un-Audited Financial Results (Standalone & Consolidated) for the Quarter and Half Year ended 30.09.2026
Announcement under Regulation 30 (LODR)-Investor Presentation
16-Nov-2026 | Source : BSEPlease refer to the attached Analysts Presentation
Corporate Actions
No Upcoming Board Meetings
Gujarat Themis Biosyn Ltd has declared 67% dividend, ex-date: 23 Sep 26
Gujarat Themis Biosyn Ltd has announced 1:5 stock split, ex-date: 10 Oct 23
Gujarat Themis Biosyn Ltd has announced 1:2 bonus issue, ex-date: 09 Aug 24
No Rights history available